Article
An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA.
Journal of internal medicine - 1 Mar 2010
Cervin C, Axler O, Holmkvist J, Almgren P, Rantala E, Tuomi T, Groop L, Dahlbäck B, Karlsson E
Abstract excerpt
OBJECTIVE: To investigate the fitness of serum apolipoprotein M (apoM) concentration as a marker for maturity-onset diabetes of the young 3 (MODY3). STUDY DESIGN AND SUBJECTS: This study consisted of two parts. A family study included 71 carriers of the P291fsinsC mutation in hepatocyte nuclear factor-1alpha (HNF-1alpha) from the Finnish Botnia study, 53 of whom were diabetic, and 75 matched family controls. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.